Vestmark Advisory Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,352
| Closed | -$384K | – | 861 |
|
|
2021
Q4 | $384K | Buy |
4,352
+165
| +4% | +$14.6K | 0.02% | 616 |
|
|
2021
Q3 | $324K | Buy |
4,187
+179
| +4% | +$13.9K | 0.02% | 637 |
|
|
2021
Q2 | $334K | Buy |
4,008
+50
| +1% | +$4.17K | 0.02% | 595 |
|
|
2021
Q1 | $299K | Sell |
3,958
-1,426
| -26% | -$108K | 0.03% | 601 |
|
|
2020
Q4 | $472K | Sell |
5,384
-153
| -3% | -$13.4K | 0.05% | 366 |
|
|
2020
Q3 | $421K | Buy |
5,537
+860
| +18% | +$65.4K | 0.06% | 351 |
|
|
2020
Q2 | $577K | Buy |
4,677
+229
| +5% | +$28.3K | 0.09% | 279 |
|
|
2020
Q1 | $376K | Buy |
+4,448
| New | +$376K | 0.07% | 312 |
|
|
2019
Q4 | – | Sell |
-4,445
| Closed | -$300K | – | 288 |
|
|
2019
Q3 | $300K | Buy |
4,445
+1,060
| +31% | +$71.5K | 0.05% | 410 |
|
|
2019
Q2 | $290K | Buy |
+3,385
| New | +$290K | 0.05% | 415 |
|